News Releases
Clinical Trials & Medical Discoveries
The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.
Most Read
- Aug 08, 2013, 13:00 ET Top 100 College Party Schools for 2013-2014
- Jul 05, 2013, 14:51 ET Don't miss the world's first free iPhone data recovery software from EaseUS
- Aug 26, 2013, 14:30 ET 2014 Honda Civic Bound to be Tweaked to Perfection
Most Emailed
- Sep 27, 2013, 06:07 ET Phoenix Defrauds Stimulus With Phony Kidnap Statistics Full Disclosure Network(R) TV Video-Internet Series
- Oct 02, 2013, 06:07 ET Exposed: Media Fears Government In A Full Disclosure Network(R) TV-Internet Series
- Sep 25, 2013, 09:00 ET McGraw-Hill Education Launches Reading WonderWorks to Help Struggling Readers Meet the Common Core State Standards
Organizations in the News
The organizations with the most activity in PR Newswire's News Room
AAA Research Reports Investors' Reports Analysts' CornerJournalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Download our 2013 SEC Filing Calendar
Our 2013 SEC Calendar includes all required SEC filings deadlines and holiday closures
New! View News by location
-
Oct 02, 2013, 03:39 ET
"GenoVive está cambiando la forma de la salud personalizada al seguir con sus esfuerzos de investigación con Harvard"
GenoVive, un innovador en soluciones de tratamiento de salud personalizadas, está liderando la lucha contra la epidemia emergente de la... -
Oct 02, 2013, 03:39 ET
„Durch fortgesetzte Forschungsbemühungen mit Harvard verändert GenoVive das Gesicht der personalisierten Medizin."
GenoVive, ein Innovator auf dem Gebiet der personalisierten Gesundheitslösungen, kämpft mit seinem hochmodernen Programm zur... -
Oct 02, 2013, 03:39 ET
« GenoVive révolutionne les soins de santé personnalisés grâce à ses recherches continues en partenariat avec Harvard. »
GenoVive, pionnier dans le domaine des soins de santé personnalisés, mène la lutte contre l'épidémie naissante de... -
Oct 02, 2013, 02:22 ET
World-first Trial for Tendon Repair Using Tendon Stem Cells Published in the Prestigious American Journal of Sports Medicine
Regenerative medicine company, Orthocell Limited (Orthocell), today announced the results of its unprecedented and successful clinical trial for... -
Oct 01, 2013, 17:00 ET
Mom's weight gain during pregnancy tied to childhood obesity
Obesity prevention may best begin before birth A study of 41,133 mothers and their children in Arkansas has shown that high pregnancy weight... -
Oct 01, 2013, 16:05 ET
Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)(Intercept), a clinical stage biopharmaceutical company focused on the development and... -
Oct 01, 2013, 16:00 ET
Xencor's XmAb5871 Enters Phase 2a Study for Autoimmune Disease
Xencor, Inc. today announced that the first patient has been dosed in the Phase 2a part of its ongoing Phase 1b/2a clinical trial of... -
Oct 01, 2013, 13:15 ET
Oncolytics Biotech Inc. Collaborators to Present Positive Clinical Trial Data at the 15th Annual World Conference on Lung Cancer
CALGARY, Oct. 1, 2013 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that abstracts detailing... -
Oct 01, 2013, 12:09 ET
In advance of treaty adoption, hair testing shows worldwide exposure to mercury
Just prior to the adoption of a global treaty on mercury[i], a new Zero Mercury Working Group[ii] report[iii] highlights the importance of the... -
Oct 01, 2013, 11:19 ET
Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
New data from Boehringer Ingelheim's hepatitis C virus (HCV) clinical development program have been accepted for presentation at the 64th... -
Oct 01, 2013, 10:40 ET
IceCure Enters a New High-Potential Market: The company received $100K-order for cryoablation consoles and probes to be used in a clinical study for the treatment of lung cancer
IceCure Medical Ltd. (TASE: ICCM) announced today that it received its first order for cryoablation systems to be used in a clinical... -
Oct 01, 2013, 10:05 ET
Case Report on 14-Year-Old Pediatric Patient Bridged to Transplant with SynCardia Total Artificial Heart Published in the Journal Perfusion
Surgeons in Phoenix, Arizona, successfully implanted the SynCardia temporary Total Artificial Heart into a 14-year-old boy with biventricular... -
Oct 01, 2013, 10:00 ET
AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
AbbVie (NYSE: ABBV) announced that new data from its phase II hepatitis C clinical development program will be presented at The Liver Meeting, the... -
Oct 01, 2013, 09:54 ET
Helsinn to Launch Sales Organization in the United States
The Swiss Helsinn Group announced today the formation of a sales organization in the US subsidiary, Helsinn Therapeutics (US) Inc. A... -
Oct 01, 2013, 09:12 ET
Elsevier's Geofacets Adds More Than 80,000 Maps in Collaboration with The Geological Society of America
Exploration research platform now contains more than 350,000 geological maps, with more content coverage in North America, offshore areas and... -
Oct 01, 2013, 09:00 ET
HuREL® Enters Into Cell-Based R&D Collaboration With Sanofi US To Validate HuRELhuman™ In Vitro Liver Tissue Co-Culture For Use In Pre-Clinical Drug Development
HuREL Corporation ("Hurel"), a world-leading provider of advanced tissue constructs and microfluidic cell-based assay platforms for pre-clinical... -
Oct 01, 2013, 08:36 ET
The Killer Instinct: Attacking Cancer Before It Develops
Cancer can be defeated before it develops—without the use of chemotherapy or radiation. Dr. Ben Lerner, co-founder of Maximized... -
Oct 01, 2013, 08:07 ET
National MS Society and GE Healthcare Join Forces to Fund Unique Imaging Study in Patients with Multiple Sclerosis
The National Multiple Sclerosis Society today announced that it has entered into a research collaboration agreement with GE Healthcare... -
Oct 01, 2013, 08:00 ET
Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Janssen R&D Ireland (Janssen) announced that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the... -
Oct 01, 2013, 08:00 ET
Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of company's third US patent for its oxidation-reduction potential diagnostic platform
Luoxis Diagnostics (a subsidiary of Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), today announced results from a recently completed clinical...
